$XXII “Bullish Charts” Promoter Rank: 19/23 22nd Century Group, Inc. Newsletter 7:32:38 AM November 7, 2022

on November 7, 2022 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Bullish Charts"

The following three charts can be used by potential investors to gauge the performance of "Bullish Charts":

43%

27 out of 62 campaigns closed down on first day

51%

32 out of 62 campaigns closed up on first day

4%

3 out of 62 campaigns had no net effect

XXII Promotional Newsletter

The following is a newsletter released by "Bullish Charts" promoting 22nd Century Group, Inc.

Caution

The following newsletter has not been verified for accuracy or completeness.

Greetings All,

The global tobacco industry is a behemoth and valued at nearly 1 trillion dollars. With estimated at USD 849.9 billion in 2021 and expected to reach USD 867.6 billion this year, the sector is one of the most profitable in the world.

Many smokers try to quit and Big Tobacco isnt doing enough to help them.

The FDA has stated that a nicotine cap, as part of its would help five million adult smokers to quit within one year, help 33 million people to avoid becoming regular smokers, and save more than eight million American lives by the end of the century this is a truly game-changing future for people who smoke and for public health overall.

This also puts an emerging NASDAQ company called 22nd Century Group NASDAQ XXII into the spotlight as the company has a product that is the ONLY combustible tobacco product that meets the low nicotine levels proposed in the FDAs

The FDAs proposed ruling calls for a tobacco product standard that requires all combustible cigarettes to contain minimally or non-addictive levels of nicotine.

Trading at just a little over $1, XXII is offering the world the first cigarette that has been authorized by the FDA to help smokers smoke less

And earlier this year XXII acquired a company that is widely regarded as a best-in-class operator with an estimated 15% share of the hemp-derived active ingredients market. This transaction is expected to DOUBLE XXIIs total revenue

With a revolutionary approach to reducing tobacco harm, revenues in the millions, a big splash entrance into the hempcannabis arena, AND a high price target of $8.50, 22nd Century Group, Inc. NASDAQ XXII looks like its on Wall Streets secret corner and could quickly capture big attention soon

23 Downing Street
Newark NJ 07105
US